Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Yan Ping Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8525-7814; OpenAlex author ID A5083147929. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

  1. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer. Co-author DOI 10.1038/s41419-021-04118-4↗
  2. The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc. Co-author PMID 32064158↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heshui Wu · 2 shared papers, 2020–2021 · strength 0.25
  2. Xin Jin · 2 shared papers, 2020–2021 · strength 0.25
  3. Dianyun Ren · 2 shared papers, 2020–2021 · strength 0.25
  4. Jian Shen · 1 shared paper, 2021 · strength 0.14
  5. Yingke Zhou · 1 shared paper, 2021 · strength 0.14
  6. Yang Gao · 1 shared paper, 2021 · strength 0.14
  7. Ping Fan · 1 shared paper, 2021 · strength 0.14
  8. Jingyuan Zhao · 1 shared paper, 2020 · strength 0.11
  9. Zibo Meng · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.